Meghana Keshavan

Meghana Keshavan

Meghana has spent the last year-and-a-half writing about biotech and healthcare for the San Diego Business Journal. Previously, she's worked for Reuters, Crain’s Detroit Business, the Detroit Free Press and WDET, a Detroit-based National Public Radio affiliate. Meghana studied biochemistry and molecular biology at Penn State University and spent five years as a self-described "research peon in a schizophrenia genetics lab."

Follow Meghana Keshavan: Twitter |


Funding Roundup: Which biotech, medtech and healthIT startups got investments this week?

Funding Roundup: Which biotech, medtech and healthIT startups got investments this week?

October 24, 2014 2:00 pm by | 0 Comments

Each week, many millions are invested into life sciences startups. There are so many that often, they get lost in the weeds. We’re keeping track for you - based on regulatory filings reported…


FDA improving medical device approval times, and also reputation – but only a little

FDA improving medical device approval times, and also reputation – but only a little

October 24, 2014 12:34 pm by | 0 Comments

It’s been tough times of late for the medical device industry - and much of it’s being pegged on the inefficiencies at the Food and Drug Administration. Indeed, faster approval times abroad mean…



J&J opening up new J-Labs incubator in Houston early next year

J&J opening up new J-Labs incubator in Houston early next year

October 24, 2014 6:00 am by | 0 Comments

Move over, Boston and San Francisco – Texas seems to positioning as the next biotech hub. Johnson & Johnson Innovation is opening up a new incubator in Houston – following…


Celgene invests in startup that measures residual cancer cells to test a drug’s efficacy

Celgene invests in startup that measures residual cancer cells to test a drug’s efficacy

October 23, 2014 3:00 pm by | 0 Comments

Celgene just made an equity investment Bay Area-based Sequenta, a biotech that’s developing a minimal residual disease test for blood cancer. The startup’s ClonoSight platform senses the remaining cancerous cells in…


NuVascular’s bioscaffolding implants mimic natural tissue – and can deliver drugs, to boot

NuVascular’s bioscaffolding implants mimic natural tissue – and can deliver drugs, to boot

October 23, 2014 9:00 am by | 0 Comments

A Boston-area bioscaffolding startup is creating a way to mimic natural tissue that also incorporates targeted drug delivery – with aims to create vascular piping that helps treat disease of the…


Surgeons, say goodbye to stitches or staples – ZipLine has an alternative

Surgeons, say goodbye to stitches or staples – ZipLine has an alternative

October 23, 2014 5:59 am by | 0 Comments

Stapling up skin post-surgery is pretty much the norm to quickly seal up wounds, but it runs a risk of infection and injury from the extra damage to already sensitive skin. Bay…


New legs for a fluorescent tech that helps measure apoptosis

New legs for a fluorescent tech that helps measure apoptosis

October 22, 2014 6:40 pm by | 0 Comments

Learning how apoptosis works – that is, the programmed death of a cell - could play an important role in helping researchers understand how debilitating diseases work – or even how to make drugs…



Nerd alert: How the mazes of Dungeons & Dragons and pharma R&D compare

Nerd alert: How the mazes of Dungeons & Dragons and pharma R&D compare

October 22, 2014 1:42 pm by | 0 Comments

The pharma industry just got a hell of a lot nerdier, thanks to a recent Forbes op-ed. It likens the maze-like research and development quagmire to the elf-infused quests seen in fantasy role-playing game Dungeons and Dragons….


A breathalyzer for hospital-acquired infection

A breathalyzer for hospital-acquired infection

October 22, 2014 6:00 am by | 0 Comments

Wisconsin startup Isomark has developed a breath-based test that can detect infection within two hours of its onset. The patented concept has wide-reaching applications – for instance, it’s proposed developing a…


Wow of the Week: A breathalyzer and video game to help smokers quit the cigs

Wow of the Week: A breathalyzer and video game to help smokers quit the cigs

October 18, 2014 8:30 am by | 0 Comments

A weapon of ash destruction. That’s what New York startup IntelliQuit‘s calling its new smoking cessation system – a nicotine breathalyzer that comes coupled with a couple of video games…


Funding Roundup: Which biotech, medtech and healthIT startups got investments this week?

Funding Roundup: Which biotech, medtech and healthIT startups got investments this week?

October 17, 2014 4:14 pm by | 0 Comments

Each week, many millions are invested into life sciences startups. There are so many that often, they get lost in the weeds. We’re keeping track for you - based on regulatory filings reported…


How dangerous IS that infectious disease? This infograph tells you

How dangerous IS that infectious disease? This infograph tells you

October 17, 2014 10:52 am by | 0 Comments

London-based data journalist David McCandless put together a pretty scatterplot about the relative dangers of infectious disease.  McCandless sums up the infograph nice: “It’s a statistical measure of how likely an…


Hey, medical device startups: You should probably apply today for the MedTech Innovator pitchfest.

Hey, medical device startups: You should probably apply today for the MedTech Innovator pitchfest.

October 17, 2014 6:00 am by | 0 Comments

Just a friendly heads up: Today’s the last day to apply for next month’s MedTech Innovator competition – a pitchfest for the early stage medical device set. Ten semi-finalists will be…


Venture firm Canaan Partners raises $675 million more; plans to invest in healthcare, tech startups

Venture firm Canaan Partners raises $675 million more; plans to invest in healthcare, tech startups

October 16, 2014 12:00 pm by | 0 Comments

Menlo Park venture firm Canaan Partners just raised $675 million for its tenth fund – with plans to invest this Fund X mostly in early stage and seed stage startups…


Twitter “astroturfing” undermining public health initiatives? Say it ain’t so!

Twitter “astroturfing” undermining public health initiatives? Say it ain’t so!

October 16, 2014 11:30 am by | 77 Comments

No one’s safe from the “Twitter bomb” – not even a public health campaign. The Chicago Department of Public Health was subject to some serious astroturfing earlier this year, a…